Opticyte’s Patient Monitor for Organ Failure Earns Breakthrough Device Designation
Opticyte’s Cell O₂ Patient Monitor has received Breakthrough Device Designation for the continuous monitoring of those at risk of organ failure.
Read MoreJan 19, 2023 | FDA Updates, Medical Equipment | 0 |
Opticyte’s Cell O₂ Patient Monitor has received Breakthrough Device Designation for the continuous monitoring of those at risk of organ failure.
Read MoreJan 18, 2023 | Cybersecurity | 0 |
In Ponemon Institute’s survey of healthcare IT professionals, many respondents indicated that ransomware attacks at their organization directly disrupted patient care.
Read MoreECRI has named gaps with recalls of home-use medical devices as the nation’s most pressing health technology safety issue for 2023.
Read MoreJan 12, 2023 | FDA Updates, Patient Care Equipment | 0 |
The U.S. FDA’s Center for Devices and Radiological Health has issued two warning letters to endoscope manufacturer Olympus Medical Systems Corp., following facility inspections.
Read MoreJan 12, 2023 | Company News | 0 |
Glassbeam has appointed healthcare veteran Richard Jones CEO and to its board of directors, effective January 9. He joins Glassbeam from Akumin, where he served as president of radiology.
Read More